Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.24
-0.03 (-0.03%)
At close: Aug 15, 2025, 2:55 PM
Verona Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 76.26M | 36.66M | 5.62M | n/a | n/a | 940.06K | n/a | n/a | n/a | 458K | n/a | n/a | n/a | n/a | 40M | n/a | n/a |
Cost of Revenue | 3.41M | 2.04M | 543K | 270.3K | 262.85K | 209.81K | 154.1K | 157.5K | 158.42K | 346K | 155.66K | 163.56K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 72.85M | 34.62M | 5.08M | -270.3K | -262.85K | 730.25K | -154.1K | -157.5K | -158.42K | 112K | -155.66K | -163.56K | n/a | n/a | 40M | n/a | n/a |
Operating Income | -10.32M | -18.34M | -40.67M | -68.5M | -27.18M | -19.26M | -14.73M | -9.96M | -22.2M | -14.25M | -15.13M | -20.51M | -25.07M | -28.47M | 6.56M | -28.55M | -22.86M |
Interest Income | 3.91M | 3.99M | 4.75M | 3.14M | 3.38M | 3.32M | 3.39M | 3.4M | 2.68M | 1.86M | 779K | 165K | 15K | 3K | 4K | 3K | 4K |
Pretax Income | -16.56M | -25.56M | -42.71M | -70.75M | -25.61M | -15.35M | -14.64M | -8.5M | -16.57M | -10.42M | -15.58M | -17.69M | -24.75M | -23.51M | 11.18M | -22.04M | -21.21M |
Net Income | -16.32M | -33.83M | -42.96M | -70.91M | -25.78M | -14.25M | -14.69M | -8.81M | -16.74M | -10.45M | -15.65M | -17.77M | -24.84M | -23.26M | 11.05M | -22.07M | -21.29M |
Selling & General & Admin | 69.11M | 45.09M | 35.2M | 48.82M | 20.16M | 14.89M | 13.35M | 12.44M | 9.59M | 8.32M | 5.29M | 5.53M | 7.44M | 5.76M | 10.88M | 7.99M | 9.28M |
Research & Development | 14.05M | 7.87M | 10.55M | 19.41M | 6.76M | 4.16M | 2.96M | -2.47M | 12.61M | 6.84M | 9.84M | 14.98M | 17.63M | 22.71M | 22.56M | 20.56M | 13.57M |
Other Expenses | n/a | n/a | n/a | 270.3K | n/a | n/a | n/a | n/a | -2.31M | -796K | -2.13M | -5.41M | -1.3M | -4.97M | -4.75M | -3.84M | -2.07M |
Operating Expenses | 83.17M | 52.95M | 45.75M | 68.23M | 26.92M | 19.05M | 16.31M | 11.9M | 19.89M | 14.37M | 13M | 15.1M | 23.76M | 23.49M | 28.69M | 24.71M | 20.79M |
Interest Expense | -10.18M | 10.32M | 9.88M | 1.76M | 1.59M | 628.42K | 401K | 740K | 293K | 230K | 116K | 91K | 84K | 85K | 86K | 85K | 84K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13M | n/a | n/a | n/a | -11.51M | n/a | n/a | n/a |
Cost & Expenses | 86.57M | 54.99M | 46.29M | 68.5M | 27.18M | 19.26M | 16.31M | 11.9M | 19.89M | 14.71M | 13M | 15.1M | 23.76M | 23.49M | 28.69M | 24.71M | 20.79M |
Income Tax Expense | -239.92K | 8.27M | 250K | 167.19K | 168.9K | -1.1M | -44K | 310K | 173K | 28K | 64K | 79K | 82K | -250K | 127K | 25K | 80K |
Shares Outstanding (Basic) | 84.93M | 81.54M | 81.49M | 81.03M | 80.71M | 59.12M | 79.78M | 79.31M | 77.68M | 75.53M | 65.2M | 60.6M | 60.24M | 59.9M | 69.07M | 58.85M | 58.68M |
Shares Outstanding (Diluted) | 84.93M | 81.54M | 81.49M | 81.03M | 80.71M | 80.27M | 79.78M | 79.31M | 77.68M | 75.53M | 68.02M | 60.6M | 60.24M | 59.9M | 64.48M | 58.85M | 58.68M |
EPS (Basic) | -0.16 | -0.42 | -0.53 | -0.88 | -0.32 | -0.24 | -0.18 | -0.11 | -0.22 | -0.14 | -0.24 | -0.29 | -0.41 | -0.39 | 0.16 | -0.38 | -0.36 |
EPS (Diluted) | -0.16 | -0.42 | -0.53 | -0.88 | -0.32 | -0.18 | -0.18 | -0.11 | -0.22 | -0.14 | -0.23 | -0.29 | -0.41 | -0.39 | 0.17 | -0.38 | -0.36 |
EBITDA | -6.09M | -82.21M | -34.53M | -53.24M | -23.19M | -14M | -13.5M | -8.34M | -15.99M | -10.01M | -15.13M | -12.27M | -17.97M | -24.57M | 11.43M | -17.76M | -14.97M |
EBIT | -6.39M | -15.24M | -32.83M | -68.06M | -23.45M | -13.56M | -14.24M | -7.76M | -16.28M | -10.19M | -15.47M | -17.6M | -24.67M | -23.43M | 11.26M | -21.96M | -21.13M |
Depreciation & Amortization | 296.13K | 259K | 268.73K | 270.3K | 263K | 208K | 155K | 157K | 157K | 151K | 157K | 165K | 163K | 162K | 162K | 152K | 153K |